Thrombospondin-1 (THBS1) and transforming growth factorbeta1 (TGFB1) are specifically up-regulated by prostaglandin F2alpha in mature corpus luteum (CL). This study examined the relationship between the expression of THBS1 and TGFB1 and the underlying mechanisms of their actions in luteal endothelial cells (ECs). TGFB1 stimulated SMAD2 phosphorylation and SERPINE1 levels in dose-and time-dependent manners in luteal EC. THBS1 also elevated SERPINE1; this effect was abolished by TGFB1 receptor-1 kinase inhibitor (SB431542). The findings here further imply that THBS1 activates TGFB1 in luteal ECs: THBS1 increased the effects of latent TGFB1 on phosphorylated SMAD (phospho-SMAD) 2 and SERPINE1. THBS1 silencing significantly decreased SERPINE1 and levels of phospho-SMAD2. Lastly, THBS1 actions on SERPINE1 were inhibited by LSKL peptide (TGFB1 activation inhibitor); LSKL also counteracted latent TGFB1-induced phospho-SMAD2. We found that TGFB1 up-regulated its own mRNA levels and those of THBS1. Both compounds generated apoptosis, but THBS1 was significantly more effective (2.5-fold). Notably, this effect of THBS1 was not mediated by TGFB1. THBS1 and TGFB1 also differed in their activation of p38 mitogen-activated protein kinase. Whereas TGFB1 rapidly induced phospho-p38, THBS1 had a delayed effect. Inhibition of p38 pathway by SB203580 did not modulate TGFB1 effect on cell viability, but it amplified THBS1 actions. THBS1-stimulated caspase-3 activation coincided with p38 phosphorylation, suggesting that caspase-induced DNA damage initiated p38 phosphorylation. The in vitro data suggest that a feed-forward loop exists between THBS1, TGFB1, and SERPINE1. Indeed all these three genes were similarly induced in the regressing CL. Their gene products can promote vascular instability, apoptosis, and matrix remodeling during luteolysis.
INTRODUCTION
The vascular bed of corpus luteum (CL) undergoes dynamic changes during its lifespan. CL formation is accompanied by intense angiogenesis, whereas the demise of the gland, initiated by prostaglandin F2 alpha (PGF2a), is associated with apoptosis and angioregression [1] [2] [3] . Recent reports in cows and sheep have shown that thrombospondin-1 (THBS1) is one of the antiangiogenic genes that are upregulated by PGF2a, specifically, in mature, PGF2a-responsive CL [4, 5] . Such a rise in THBS1 was not detected during the refractory stage (before Day 5 of the cycle) [5] , or in the CL of pregnant animals [6] . THBS1 is a large protein with several domains that act via multiple mechanisms [7] . The THBS1 gene is expressed both in luteal endothelial cell (EC) and steroidogenic cells, and is hormonally regulated; it is the direct target of PGF2a in these cells, as demonstrated by in vitro studies [5, 8] . Furthermore, THBS1 expression was inhibited by luteinizing signals (LH and insulin) in granulosa cells. Functionally, THBS1 reduced luteal EC numbers and promoted apoptosis by activating caspase 3 [8] . Interesting relationships between THBS1 and FGF2, a known luteal proangiogenic factor, were noted. Specifically, THBS1 and FGF2 reciprocally inhibited each other's gene expression [8] . Moreover, THBS1 inhibited FGF2 functions (i.e., its ability to promote cell proliferation, migration, and survival) [8] . These results suggest that THBS1 is expressed in a physiologically relevant manner and plays a role in the luteolytic process. THBS1 was shown to activate latent transforming growth factor-beta1 (TGFB1), allowing its binding to its receptors [9] . TGFB1 levels were shown to be elevated in cow and rat CL during luteal regression [4, 10, 11] . However, whether latent TGFB1 is activated by THBS1 in luteal cells is still unknown. In addition, the detailed characterization of THBS1 actions in luteal cells or its signaling pathways by which it exerts its effects in luteal ECs is not yet available. This study was therefore designed to shed light on the relationship between the expression of THBS1 and TGFB1 and the underlying mechanisms of their actions in luteal ECs.
MATERIALS AND METHODS

CL Collection
CL collection was described in detail in our previous publication [4] . Briefly, CL were collected after epidural anesthesia on Day 4 or Day 11 (n ¼ 5 for each stage) of the estrous cycle, which was approved by the institutional ethics committee. CL were diced and snap frozen in liquid nitrogen and stored at À808C until RNA extraction with RNAeasy kits. Total RNA was subjected to reverse transcription for synthesis of cDNA, which served as a template for synthesis of full-length biotin-labeled cRNA with the GeneChip HT One-Cycle Target Labeling and Controls Kit (Affymetrix, Santa Clara, CA).
Isolation and Culture of Luteal ECs
The procedure for luteal EC enrichment was described in detail previously [12] . Briefly, CL were dispersed using sequential incubations with collagenase. Cells were then incubated with BS-1-coated magnetic beads. The adherent cells were washed and concentrated using a magnet until the supernatant was free of cells. BS-1-positive cells (the enriched luteal EC fraction) were plated in Dulbecco modified Eagle medium (DMEM)/F-12 containing 1% L-glutamine and 1% penicillin/streptomycin (Biological Industries, Kibbutz Beit Haemek, Israel) with 10% fetal calf serum (FCS; Biological Industries) on collagen type I-coated plates (Surecoat; Advanced BioMatrix, San Diego, CA). Colonies of luteal ECs were trypsinized with 1% crystalline trypsin (Biological Industries), collected, and reseeded; this process was repeated until homogeneous cell cultures were visualized. Cell identity was verified using EC markers (CD31, EDN1), and the lack of contamination by smooth muscle cells (ACTAG2 expression) and fibroblasts (COL1A1 expression) was evaluated. Cells in this study were derived from at least three CL and used in passages 4-10.
Cell Culture and Drug Treatment
Luteal ECs were seeded in six-well dishes (200 000 cells/well) and cultured overnight in DMEM/F-12 medium containing 10% FCS. The next day, the cells were transferred to starvation medium (0.5% bovine serum albumin [BSA], 0.1% FCS) for 24 h and were then incubated with 10-1000 ng/ml recombinant human THBS1 (Genetech, Ingolstadt, Germany), 0.1-5 ng/ml recombinant human TGFB1 (ProSpec-Tany TechnoGene, Ltd., Rehovot, Israel), 1 lM SB431542 (Sigma-Aldrich, St. Louis, MO), 5 lM LSKL (Sigma-Aldrich), 10 ng/ml recombinant latent human TGFB1 (Sigma-Aldrich), and 1 lM SB203580 (Sigma-Aldrich) for 1, 3, 6, 10, 15, 24, and 48 h. Cells not treated were used as a blank control. Following drug treatments, these cells were subjected to various measurements.
RNA Extraction and Real-Time PCR
Total RNA was isolated from cells using Tri Reagent (Molecular Research Center, Cincinnati, OH) according to the manufacturer's instructions. A total of 1 lg of total RNA was reverse transcribed using M-MuLV Reverse Transcriptase (200 units/ll), M-MuLV RT Buffer (New England Biolabs, Ipswich, MA), random primer (100 nM), oligo-dT (100 uM), and dNTPs mix (100 mM) (Bioline Reagents Limited, London, UK). Real-time PCRs were performed using the LightCycler 96 system (Roche Diagnostics, Indianapolis, IN) using Platinum SYBR Green (SuperMix, Invitrogen, Carlsbad, CA). The glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene was used as the housekeeping gene. The threshold cycle number (Ct) was used to quantify the relative abundance of the gene; arbitrary units were calculated as 2 . Expression of specific gene mRNA was normalized relative to the abundance of GAPDH mRNA. Sequences of primers used for quantitative RT-PCR are listed in Table 1 .
Western Blot Analyses
Proteins were extracted by adding sample buffer (32) , separated by 7.5%-12.0% SDS-PAGE, and subsequently transferred to nitrocellulose membranes, as previously reported [5] . Membranes were blocked for 1 h in TBST (20 mmol/L Tris, 150 mmol/L NaCl, and 0.1% Tween 20; pH 7.6) containing 5% low-fat milk, and then incubated overnight at 48C with rabbit antiphosphorylated Smad (phospho-Smad) 2 (1:1000; #3101, Cell Signaling Technology, Beverly, MA), rabbit anti-phospho-p38 mitogen-activated protein kinase (phospho-p38 MAPK; 1:1000, #9215; Cell Signaling Technology), rabbit anti-cleaved caspase 3 (1:1000; #9661, Cell Signaling Technology), and rabbit anti-p44/42 total MAPK (1:50 000, Sigma-Aldrich) in 1% low-fat milk.
The membranes were incubated with peroxidase-conjugated goat anti-rabbit IgG (heavy þ light chains) for 1 h at room temperature. A chemiluminescent signal was generated with SuperSignal (Thermo Fisher Scientific, Rockford, IL), and the membranes were exposed. The signal was analyzed by using the Gel-Pro Analyzer version 3.0 (Media Cybernetics, Inc., MD) and normalized to total p44/42 MAPK in the same sample to correct for amount of protein loaded.
Determination of Viable Cell Numbers
Cells were seeded in 96-well dishes (3000 cells/well) and cultured overnight in DMEM/F-12 medium containing 10% FCS. The next day, the cells were transferred to starvation medium (0.5% BSA, 0.1% FCS) for 24 h and were then incubated for 24 h with 250-1000 ng/ml THBS1, 0.1-5 ng/ml TGFB1 alone, or with 1 lM SB431542 or 1 lM SB203580. Cell numbers were estimated, as previously described [13] , using the XTT kit (Biological Industries), which measures the reduction of a tetrazolium component by the mitochondria of viable cells. On the day of measurement, XTT was added according to the manufacturer's instructions. Plates were incubated at 378C for 2 h. The absorbance was read at 450 nm (reference absorbance, 630 nm).
Transfection of Cells
Cells were trypsinized, seeded in six-well plates, and cultured for up to 24 h in DMEM/F-12 medium containing 10% FCS. Then cells were transfected using Lipofectamine 2000 reagent (Invitrogen), according to the manufacturer's protocol, at 1% FCS. Cells were transfected with siRNA sequences (GeneCust, Luxembourg) targeting (50 nmol/L) siTHBS1 or scrambled siRNA. The sequence of siTHBS1 was sense (S), CUCAGUUACCAUCUGCAAAdTdT, antisense (AS), UUUGCAGAUGGUAACUGAG, corresponding to bases 1176-1194 of the THBS1 mRNA sequence. The scrambled siRNA sequence/ negative control was S, UUCUCCGAACGUGUCACGUdTdT, and AS, ACGUGACACGUUCGGAGAAdTdT. Total RNA or proteins were then extracted from cells 48 and 72 h after transfection (for mRNA and protein levels, respectively).
Statistical Analyses
Data are presented as means 6 SEM; experiments were repeated at least three times. Statistical analyses were performed using Student t-test or one-way ANOVA, followed by Bonferroni multiple comparison tests, when appropriate. In all analyses, a value of P , 0.05 was considered significant. Statistical analysis of the experimental data was performed using SigmaPlot Systat software (Systat, San Jose, CA).
RESULTS
Luteal Stage-Specific Expression of PGF2a-Induced Genes
We have previously reported the time-dependent expression of THBS1 and TGFB1 in CL after administering PGF2a on Days 4 (PGF2a refractory) and 11 (PGF2a responsive) of the bovine cycle [4, 5] . Figure 1 presents the expression of an additional gene-SERPINE1 (serine protease inhibitor, also known as plasminogen activator inhibitor-1 [PAI-1], a downstream target of TGFB1 [14] ), in relation to these two genes. Like both THBS1 and TGFB1, SERPINE1 expression showed marked luteal stage-specific expression with extensive responses observed on Day 11 ( Fig. 1) . In fact, the magnitude of SERPINE1 response on Day 11 exceeded that of THBS1 or TGFB1 (at 4 h, the postinjection expression of THBS1 and TGFB1 was elevated approximately 4-fold vs. 60-fold for SERPINE1 relative to the 0-h time point; Fig. 1 ). Gene expression profile on Day 4 revealed other differences between these genes: TGFB1 was not at all elevated in response to PGF2a, and was even reduced at 24 h relative to the 0-h time point. In contrast, SERPINE1 and THBS1 were transiently, but significantly, elevated at 4 h and decreased thereafter (Fig. 1) . ). C) Serum-starved cells were incubated for 3-48 h with 1 ng/ml of TGFB1 (solid black line) or 200 ng/ml of THBS1 (dashed line). Cells were then harvested and SERPINE1 mRNA was determined using quantitative PCR (qPCR). The data shown are the percentage of the control (100%). Data are from four independent experiments. Results are presented as means 6 SEM. Asterisks indicate significant differences from the control group (*P , 0.05, **P , 0.01, ***P , 0.001).
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Transcriptional Regulation of THBS1, TGFB1, and SERPINE1 in Cultured Luteal ECs
To examine the causal relationship between these genes and to determine whether TGFB1 and THBS1 affect the expression of SERPINE1, we reverted to in vitro studies using luteal ECs, which express all three genes. First, we examined the dosedependent response of cells treated with TGFB1 and THBS1 (Fig. 2, A and B) . In both cases, there was a concentrationdependent rise in the level of SERPINE1 mRNA. The maximal effect was achieved with 1 ng/ml TGFB1 (3.5-fold that of control; Fig. 2A ). Increasing THBS1 doses (50-500 ng/ml) continuously elevated SERPINE1 levels without reaching a plateau (Fig. 2B) ; higher levels of THBS1 were not examined, due to its strong apoptotic effect. Time-course experiments revealed that the maximal induction of SERPINE1 mRNA was attained after 15 h of treatment with either THBS1 or TGFB1 (Fig. 2C) .
Next, we examined whether SERPINE1 expression in luteal ECs is affected by endogenous THBS1. For that purpose, we used a specific siRNA construct to silence THBS1 in these cells. This construct effectively reduced THBS1 mRNA by approximately 70% (P , 0.001) [8] . Together with THBS1 silencing, SERPINE1 mRNA was significantly decreased (55% from the negative control; P , 0.001; Fig. 3A) , while the expression of TGFB1 was not altered in THBS1-silenced cells (Fig. 3A) . Ablation of THBS1 also resulted in lower levels of phospho-SMAD2 (Fig. 3B) , a signaling molecule of TGFB1 [15] . TGFB1 up-regulated its own mRNA levels (approximately a 2-fold change; P , 0.001) and up-regulated the levels of THBS1 mRNA in luteal ECs. The specificity of TGFB1 on THBS1 and TGFB1 expression was demonstrated by use of SB431542-a selective TGFB1 receptor-1 (TGFBR1) kinase inhibitor, which abolished TGFB1 actions (Fig. 4) .
THBS1-Induced SERPINE1 Expression Is TGFB1 Dependent
The effect of TGFB1 on SERPINE1 mRNA was eliminated by pretreatment of cells with SB431542 (Fig. 5) . Importantly, the effect of THBS1 was also abolished with TGFBR1 inhibitor, implying that THBS1 may act via TGFB1. In support of these findings, the LSKL peptide partially, but significantly, inhibited the up-regulation of SERPINE1 induced by THBS1 (Fig. 5) .
Latent TGFB1 Is Activated in a THBS1-Dependent Manner
Similarly to the TGFB1 form, inactive or latent TGFB1 elevated SERPINE1 mRNA expression, but at 10-fold higher 
FIG. 4. Effects of TGFB1
(1 ng/ml) on its own mRNA expression and on THBS1 mRNA in the presence or absence of SB431542 (1 lM). At 10 h after treatment, the cells were harvested for determination of TGFB1 and THBS1 mRNA. The data shown are the percentage of the control. Data are from five independent experiments. Results are presented as means 6 SEM. Asterisks indicate significant differences from the control (*P , 0.05, ***P , 0.001).
FIG. 5. THBS1-induced SERPINE1
expression is TGFB1 dependent. Cell were incubated (10 h) with 1 ng/ml TGFB1 or 500 ng/ml THBS1 with or without 1 lM SB431542. THBS1 was also incubated with 5 lM LSKL. SERPINE1 mRNA was determined by qPCR. Results are presented as means 6 SEM (n ¼ 5). Asterisks indicate significant differences from the control (*P , 0.001). Connecting lines indicate statistical differences between two bars.
FARBEROV AND MEIDAN concentrations (Fig. 6A) , suggesting that the latent form can be endogenously activated. As alluded to before, THBS1 is one of the few molecules capable of cleaving latent TGFB1. Indeed, we observed that SERPINE1 mRNA was significantly higher in cells incubated with 500 ng/ml THBS1 than in cells treated with only latent TGFB1 (P , 0.05) (Fig. 6A) . Similarly, latent TGFB1 elevated the levels of phospho-SMAD2, as compared with the control, and this was further elevated by THBS1 treatment (P , 0.05; Fig. 6B ). However, THBS1 alone could not elevate the levels of phospho-SMAD2 (data not shown). Addition of the LSKL peptide significantly inhibited latent TGFB1-induced phospho-SMAD2 (P , 0.001; Fig. 6C ), further supporting the notion that THBS1 activates latent TGFB1.
The data presented so far suggest that THBS1 acts via TGFB1; however, the results described in Figures 7 and 8 portray THBS1 actions that are TGFB1 independent.
Regulation of p38 MAPK Phosphorylation by TGFB1 and THBS1
TGFB1 utilizes a multitude of intracellular signaling pathways, in addition to SMAD phosphorylation [16] . The best-characterized signaling pathway, except SMAD, is the activation of the p38 MAPK cascade [15] . Using antiphosphorylated p38 MAPK (phospho-p38) antibodies, which recognize p38 phosphorylated on Thr180 and Tyr182, we observed that TGFB1-stimulated p38 phosphorylation acts 1 h after its addition and returned to basal levels after 6 h. THBS1, in contrast to TGFB1, only slightly increased phospho-p38 after 1 h, but induced a robust phospho-p38 protein levels after 6 h of incubation (Fig. 7) .
Effects of THBS1 and TGFB1 on Luteal EC Viability
We next compared the effects of THBS1 and TGFB1 on the viability of luteal ECs (Fig. 8) . Adding TGFB1 only moderately (about 30%) reduced viable luteal EC numbers (Fig. 8A) . SB431542 blocked the effect of TGFB1 on cell viability (Fig. 8C) , whereas the number of cells treated with FIG. 6 . THBS1 elevated latent TGFB1 actions. Serum-starved cells were incubated with 10 ng/ml of latent TGFB1, 500 ng/ml THBS1, or latent TGFB1 together with 500 ng/ml THBS1. At 10 h after treatment, the cells were harvested for determination of SERPINE1 mRNA (A) using qPCR or after 1 h for phospho-SMAD2 (B). C) Cells were treated with latent TGFB1 alone or together with 5 lM LSKL for 1 h. Phospho-SMAD2 was determined by Western blotting and normalized relative to the abundance of total MAPK (p44/42). A representative Western blot is shown. Densitometric quantifications are shown as the percentage change from the control. Results are presented as means 6 SEM (the n values for A, B, and C were 4, 3, and 3, respectively). Asterisks indicate significant differences from the control (*P , 0.001). Connecting lines indicate statistical differences between two bars.
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p38 MAPK pathway inhibitor (SB203580) remained similar to TGFB1 given alone (Fig. 8C) . In contrast, treatment for the same time duration with recombinant THBS1 dramatically reduced the number of luteal ECs (80% at the highest dose of 1000 ng/ml THBS1; Fig. 8B) ; however, use of TGFBR1 inhibitor (SB431542) did not influence the strong apoptotic effect of THBS1 (Fig. 8B) . Interestingly, however, inhibition of the p38 MAPK pathway resulted in augmented THBS1 action, further lowering the number of cells (Fig. 8B) .
Furthermore, we found that treatment with THBS1 and TGFB1 elevated cleaved (active) caspase 3 levels in luteal ECs after 6-h incubation (Fig. 8D) . Data on caspase 3 activation are in good agreement with the cell viability assays presented in Figure 8 . THBS1 was significantly more effective than TGFB1 (2.5-fold higher; Fig. 8D ). Pretreatment with SB431542 successfully suppressed a TGFB1-dependent increase in active caspase 3 (as was also observed in cell numbers; Fig. 8C ), but this inhibitor did not alter the amount of active caspase 3 in cells treated with THBS1 (compare Figs. 8B and 8D ).
DISCUSSION
The results of this study indicate that THBS1 actions on luteal ECs entail TGFB1-dependent as well as TGFB1-independent mechanisms. We provide empirical evidence showing that ability of THBS1 to activate latent TGFB1 in luteal ECs results in its TGFB1-dependent actions, which affect canonical TGFB1 downstream molecules, signal (SMAD2 phosphorylation), and gene expression (SERPINE1). However, the apoptotic effects of THBS1, reduced viable cell numbers, and the activation of a caspase 3 precursor were not mediated by TGFB1.
Our previous reports showed that THBS1 contributes to luteolytic cascade by promoting proapoptotic, antiangiogenic activities [5, 8] . The current study sheds light on the relationship between the expression of THBS1 and TGFB1 and the underlying mechanisms of their actions in luteal ECs.
THBS1 is a large protein with several domains that act via multiple mechanisms [7, 17] . Previously, we have demonstrated that THBS1 is an antiangiogenic compound that can inhibit FGF2 mRNA expression and activity. Ability of THBS1 to inhibit FGF2 is partly mediated by THBS1 type III repeats, which can sequester FGF2 [18] . Small molecule 27 (type III repeats mimetic [19] ) inhibited FGF2-induced luteal EC proliferation and migration. Here, we extended these studies to show other luteal activities of THBS1 that are mediated by other domains. Some of these activities were dependent on TGFB1 activation, as detailed below.
TGFB1 is synthesized as a single inactive polypeptide before being proteolytically processed into mature TGFB1 and a latency-associated peptide (LAP). The KRFK sequence, found between the first and second type I repeats of THBS1 [20] , interacts with the conserved site near the amino terminus of LAP (LSKL); consequently, it displaces LAP and renders TGFB1 accessible to its receptors (TGFBR1; ALK5 and TGFBR2) [9, 21] . TGFB1 elicits a wide range of cellular FARBEROV AND MEIDAN responses that modulate cell proliferation, differentiation, and apoptosis [22, 23] . In the CL, TGFB1 inhibits progesterone production [10] , disrupts the angiogenic potential of ECs, and induces their death [8, 24] . The binding of TGFB1 to its receptors activates SMAD proteins [15] . Phospho-SMAD2 and -SMAD3 form a heteromeric complex with SMAD4, which translocates to the nucleus and binds to the promoters of TGFB1-targeted genes, including SERPINE1 [14, 25] . The SERPINE1 gene encodes endothelial PAI-1, a member of the serine protease inhibitor family. PAI-1 inhibits tissue plasminogen activator and urokinase plasminogen activator. These two convert plasminogen to plasmin, a strong proteolytic enzyme. Therefore, PAI-1 is a primary negative regulator of plasmindriven proteolysis [26] [27] [28] . Thus, SERPINE1 is a potent profibrotic factor; excessive PAI-1 expression contributes to accumulation of collagen and other extracellular matrix proteins, and preserves scaring [29] [30] [31] . An increase in SERPINE1 was also demonstrated in sheep and cow regressing CL [6, 32, 33] . The scaring, profibrotic actions of SERPINE1 may well promote the transition of active CL to corpus albicans.
The current study provides strong evidence that THBS1 activates TGFB1 in CL-derived ECs. First, THBS1-elevated SERPINE1 was abolished by a selective TGFBR1 kinase inhibitor. Second, THBS1 markedly increased the effects of latent TGFB1 on SMAD2 phosphorylation and SERPINE1 mRNA. Third, THBS1 silencing significantly decreased the expression of SERPINE1 and reduced the levels of phospho-SMAD2. Fourth, THBS1 actions on SERPINE1 were inhibited partially by LSKL peptide; LSKL also reduced phospho-SMAD2 levels elevated by latent TGFB1. The partial inhibition of LSKL may result from insufficient competing molecule concentration and lower affinity of this short peptide compared to LAP.
Like luteal ECs, the other major cell constituent of the CLthe steroidogenic cells-also express and respond to THBS1. We have reported previously that THBS1 expression [8] in luteinized granulosa cells is hormonally regulated in a ) alone (black), or with SB431542 (1 lM; red) or SB203580 (1 lM; green). C) TGFB1 (1 ng/ml) with SB431542 (1 lM) or SB203580 (1 lM). Cell viability (as the percentage of the control) was determined using XTT, as detailed in Materials and Methods. D) Caspase 3 activation: cells were treated for 6 h with 500 ng/ml THBS1 or 1 ng/ml TGFB1 alone or with 1 lM of SB431542. Active caspase 3 (percent of the control) was determined by Western blotting and normalized relative to the abundance of total MAPK (p44/42). Results are presented as means 6 SEM. The n values for A, B, C, and D were 4-5, 5, and 3 respectively). Asterisks indicate significant differences from the control (*P , 0.05, **P , 0.01, ***P , 0.001). # Significant differences between THBS1 alone or present in SB203580 (P , 0.05). Connecting lines indicate statistical differences between two bars.
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physiologically meaningful manner. Luteinized granulosa cells also express TGFB1 (data not shown); therefore, these cells can release THBS1 and latent TGFB1 to the extracellular milieu of the CL, contributing, alongside the luteal ECs, to elevation of active TGFB1.
Here, we also report other TGFB1-independent effects of THBS1. THBS1 exhibited significantly stronger proapoptotic effects on luteal ECs than did TGFB1 (80% maximum inhibition of cell numbers vs. 30%, respectively), which was mediated by proportional caspase 3 activation. Notably, the TGFBR1 inhibitor did not abolish the profound apoptotic effect of THBS1. The question then arises-what is the mechanism underlying THBS1 proapoptotic action? In the absence of CD36 in luteal ECs, the cell surface receptor CD47 on these cells [8] can be the receptor type that mediates this function. THBS1 binds CD47 in a high-affinity manner through its C-terminal domain. Increased expression of CD47 was reported to correlate with increased EC apoptosis [34] [35] [36] [37] . Nevertheless, this proposition requires further studies.
Besides SMAD phosphorylation, TGFB1 can also signal via alternative signaling pathways, including MAPK [15] . A rapid activation of p38 MAPK by TGFB1 has been demonstrated in many cells types, as also demonstrated in luteal ECs here. Importantly, however, treatment with a specific inhibitor of p38 kinase (SB203580) did not modulate the effect of TGFB1 on cell viability.
Here, THBS1 was also able to activate the p38 MAPK pathway, but with a different temporal pattern as compared to TGFB1: phosphorylation of p38 MAPK occurred only after 6 h of treatment, suggesting indirect action. Moreover, inhibition of the p38 pathway by SB203580 augmented the proapoptotic action of THBS1, suggesting that p38 pathway is important for luteal EC survival. In fact, activation of p38 MAPK has been shown to be essential for cell survival in response to DNA damage, and possibly repairs DNA prior to a mitotic catastrophe [38] . Caspase 3 has been identified as a key protease that can disrupt essential homeostatic processes and can initiate the degradation of genomic DNA [39] . In our study, we observed that elevated cleaved caspase 3 levels were already evident after 6 h of treatment with THBS1. Phosphorylation of p38 MAPK also occurred at the same time point, suggesting that activation of the p38 pathway in luteal ECs was initiated, as a protective mechanism, by DNA damage induced by THBS1.
In summary, in the young, Day-4 CL, SERPINE1 pattern followed that of THBS1, suggesting, once again, that THBS1 is responsible for the induction of SERPINE1 (via TGFB1). The transient nature of THBS1, and consequently of SERPINE1, may contribute to the resistance to luteolysis in young CL [2, 3] . In contrast to the CL, early in the cycle, SERPINE1 is strikingly induced in the regressing CL 4 and 24 h after administering PGF2a, in a pattern that closely resembles that of THBS1 and TGFB1. The in vitro data suggest that this relationship is causal. THBS1 and TGFB1 are directly induced by PGF2a in luteal cells [5] . THBS1 then activates latent TGFB1, which binds its receptors, phosphorylates SMAD2, and up-regulates SERPINE1. Furthermore, our findings indicate that TGFB1 can enhance its own mRNA expression and that of THBS1, which would lead to further induction of SERPINE1. The feed-forward loop provides a means to sustain and amplify the expression of these genes during luteolysis. Their gene products are expected to promote vascular instability, as well as apoptosis and matrix remodeling of the regressing CL.
